Follow CGSP on Social Media

Listen to the CGSP Podcast

The Seychelles Is the New Focal Point to Evaluate the Effectiveness of Chinese-Made Vaccines

A nurse holds a box of the first dose of the Chinese COVID-19 vaccine produced by Sinopharm at the Seychelles Hospital in Victoria, on January 10, 2021. Rassin VANNIER / AFP

A new wave of COVID-19 infections is sweeping across the tiny Indian Ocean island of The Seychelles. This wasn’t supposed to happen. With nearly 60% of its people vaccinated, The Seychelles has a higher inoculation rate than any other country and was widely presumed to be insulated from the outbreak that’s now ravaging countries on both sides of the Indian Ocean.

But now that infection rates have almost doubled, prompting the government to reinstitute lockdowns, there are newfound concerns that the vaccines people received are not working as expected. What’s most troubling, though, is that a third of the new infections are among those who’ve already been vaccinated — most with the Chinese-made jab from Sinopharm that was given to 57% of the entire population.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Global South Project?

Independent

The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.